Matthias Alder, Chief Executive Officer at Gain Therapeutics, Inc. (GANX), sold 1,820 shares at $2.50 ($5K) on 2023-12-07, disclosed to the SEC on 2023-12-14.
Open-market sale of $5k GANX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MITI | SELL | 2010-01-27 | $83K | — | Filing → |
| MITI | SELL | 2010-01-21 | $72K | — | Filing → |